Genetic Testing for Men with Metastatic Prostate Cancer (GENTleMEN Study)
GENTleMEN Study: Genetic Testing for Men with Metastatic Prostate Cancer
About the Study
The goal of this research study is to determine if online genetic education and testing with online telephone genetic counseling is an acceptable method of delivering genetic testing to men with metastatic prostate cancer.
This study involves undergoing genetic counseling and genetic testing for inherited cancer risk.
For more information, visit the study website.
Type of Study
This is an observational study. There is no randomization. All participants will go through the same process.
What the Study Entails
Participants who qualify for this study will:
- Provide consent/permission
- Fill out personal and family health history information
- Provide saliva sample for medical-grade genetic testing (saliva sample) to look for mutations in 30 genes associated with inherited cancer risk
- Complete a series of online questionnaires regarding their experience
- All participants will receive pre- and post- genetic testing education by video
- Additionally, some participants may undergo genetic counseling over the phone after genetic testing and all participants will have access to genetic counseling over the phone.
There is no travel required for this study. People can participate from anywhere in the United States as long as they have a personal email and internet access.
Men can participate if they are:
- Are 18 years of age or older
- Are able to read and speak English and have a valid mailing address in the U.S.
- Have a personal history of metastatic prostate cancer (cancer that has spread to distant parts of the body)
- Are willing to provide a saliva sample for the purpose of genetic testing for cancer risk (at no cost)
- Are willing to complete several questionnaires for up to six months.
- Have a personal email, access to the internet and a reliable U.S. mailing address.
Men are excluded if they:
- Unable to read, speak, and understand English
- Unable or unwilling to access the internet
- Previous bone marrow transplant
- Active hematologic malignancy (cancer that begins in blood-forming tissue, such as leukemia or lymphoma)